John Langlands
Chief Operating Officer presso RAKOVINA THERAPEUTICS INC.
Patrimonio netto: 3 700 $ in data 31/03/2024
Profilo
John Langlands is the founder of Medasystems, Inc. which was founded in 2021.
Currently, he is the Chief Operating Officer at Rakovina Therapeutics, Inc. and also works as a Principal at Langlands & Associates Consulting, Inc. He previously worked as a Director-Clinical Research at EACOM Timber Corp.
Dr. Langlands holds a doctorate degree from the University of Strathclyde.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
28/08/2023 | 50 000 ( 0.08% ) | 3 700 $ | 31/03/2024 |
Posizioni attive di John Langlands
Società | Posizione | Inizio |
---|---|---|
RAKOVINA THERAPEUTICS INC. | Chief Operating Officer | - |
Langlands & Associates Consulting, Inc. | Corporate Officer/Principal | - |
Precedenti posizioni note di John Langlands
Società | Posizione | Fine |
---|---|---|
EACOM Timber Corp.
EACOM Timber Corp. Forest ProductsNon-Energy Minerals EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada. | Chief Tech/Sci/R&D Officer | 01/01/2008 |
Medasystems, Inc.
Medasystems, Inc. Packaged SoftwareTechnology Services Medasystems, Inc. is a software development company based in Menlo Park, CA. Medasystems specializes in developing software that streamlines the handling of requests for experimental therapies from healthcare providers. The company's secure and GXP compliant application acts as a centralized environment, connecting physicians and pharmaceutical companies to facilitate patient access to investigational therapies. The platform streamlines physician inquiries to life science companies for investigational medicine, including expanded access or compassionate use, post-trial access, and investigator-initiated studies. Medasystems provides pharmaceutical manufacturers with software and tools to streamline expanded access or compassionate use requests, as well as the evaluation of IIS or IST proposals, and the management of post-trial access. Medasystems, Inc. was founded by Jeffrey Thibeault, Matthew Rosen, and John Langlands. Fiona Smythe has been the CEO of the company since 2021. | Founder | - |
Formazione di John Langlands
University of Strathclyde | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
RAKOVINA THERAPEUTICS INC. | Finance |
Aziende private | 3 |
---|---|
EACOM Timber Corp.
EACOM Timber Corp. Forest ProductsNon-Energy Minerals EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada. | Non-Energy Minerals |
Langlands & Associates Consulting, Inc. | |
Medasystems, Inc.
Medasystems, Inc. Packaged SoftwareTechnology Services Medasystems, Inc. is a software development company based in Menlo Park, CA. Medasystems specializes in developing software that streamlines the handling of requests for experimental therapies from healthcare providers. The company's secure and GXP compliant application acts as a centralized environment, connecting physicians and pharmaceutical companies to facilitate patient access to investigational therapies. The platform streamlines physician inquiries to life science companies for investigational medicine, including expanded access or compassionate use, post-trial access, and investigator-initiated studies. Medasystems provides pharmaceutical manufacturers with software and tools to streamline expanded access or compassionate use requests, as well as the evaluation of IIS or IST proposals, and the management of post-trial access. Medasystems, Inc. was founded by Jeffrey Thibeault, Matthew Rosen, and John Langlands. Fiona Smythe has been the CEO of the company since 2021. | Technology Services |
- Borsa valori
- Insiders
- John Langlands